Andrea is a 32-year-old female who had a TAH and BSO for severe endometriosis six weeks ago. When she returned to her gynecologist's office for her six week post-op check up, she told her physician that she was experiencing hot flashes, night sweats, and had difficulty sleeping. Her physician told her she was going through an artificially-induced menopause because of the surgery. He discussed several different treatment options with her, including hormone replacement therapy. She told him she wanted to weigh her options and they both agreed she should schedule a follow-up appointment in one week to set up a treatment plan.
Dx: Post-procedural menopause; status post TAH/BSO
What will be an ideal response?
Question 2
Patient is a 19-year-old sophomore at the local university. She has just recently recovered from a bout with meningitis. She is seen at the outpatient clinic at McGraw Hospital. She is complaining of extreme thirst and polyuria, muscle weakness, and headache. On physical exam, she is moderately dehydrated as evidenced by dry mucous membranes. Labs confirmed the dehydration; she is markedly hypernatremic. Fearing she may have had a relapse of the meningitis, the physician ordered an MRI of the brain. Based on the results of the tests, the physician ordered a water deprivation test be done in the office.
Patient was subsequently diagnosed with diabetes insipidus. DDAVP was prescribed. The patient was educated about her condition and how to manage the symptoms. She was asked to return to the outpatient clinic in two weeks to monitor her progress.
Dx: Diabetes insipidus
What will be an ideal response?
The female brain
(A) The male urethra. (B) The female urethra.
Hemophilia inheritance pattern between a female hemophilia carrier and a male without hemophilia.
Organs of the urinary system. This illustration is an anterior view of a female with the abdominal w
Elizabeth, a married 35-year-old woman, always thought that she followed a sensible diet
One year ago, Christos bought 1000 units of the Dominion Aggressive Growth Fund at $20.35 per ...